136 related articles for article (PubMed ID: 2588304)
1. 3 beta-hydroxyandrost-4-en-6-one derivatives as aromatase inhibitors.
Numazawa M; Mutsumi A; Tsuji M
Steroids; 1989 Sep; 54(3):299-311. PubMed ID: 2588304
[TBL] [Abstract][Full Text] [Related]
2. Competitive inhibition and suicide inactivation of human placental aromatase by androst-4-ene-3,6-dione derivatives and 3 alpha-methoxyandrost-4-ene-6,17-dione.
Numazawa M; Mutsumi A; Kigawa H
Chem Pharm Bull (Tokyo); 1990 Nov; 38(11):3076-80. PubMed ID: 2085891
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biochemical studies of 16- or 19-substituted androst-4-enes as aromatase inhibitors.
Numazawa M; Mutsumi A; Hoshi K; Oshibe M; Ishikawa E; Kigawa H
J Med Chem; 1991 Aug; 34(8):2496-504. PubMed ID: 1875347
[TBL] [Abstract][Full Text] [Related]
4. A time-dependent inactivation of aromatase by 19-oxygenated androst-4-ene-3,6,17-triones.
Numazawa M; Mutsumi A; Hoshi K; Kigawa H; Oshibe M
J Steroid Biochem Mol Biol; 1991 Dec; 39(6):959-66. PubMed ID: 1751396
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and evaluation of bromoacetoxy 4-androsten-3-ones as active site-directed inhibitors of human placental aromatase.
Numazawa M; Tsuji M; Osawa Y
Steroids; 1986; 48(5-6):347-59. PubMed ID: 3445287
[TBL] [Abstract][Full Text] [Related]
6. Thiol-containing androgens as suicide substrates of aromatase.
Bednarski PJ; Porubek DJ; Nelson SD
J Med Chem; 1985 Jun; 28(6):775-9. PubMed ID: 4009599
[TBL] [Abstract][Full Text] [Related]
7. Studies directed toward a mechanistic evaluation of aromatase inhibition by androst-5-ene-7,17-dione. Time-dependent inactivation by the 19-nor and 5 beta, 6 beta-epoxy derivatives.
Numazawa M; Tachibana M
Steroids; 1997 Jul; 62(7):516-22. PubMed ID: 9253790
[TBL] [Abstract][Full Text] [Related]
8. Interactions of thiol-containing androgens with human placental aromatase.
Bednarski PJ; Nelson SD
J Med Chem; 1989 Jan; 32(1):203-13. PubMed ID: 2909733
[TBL] [Abstract][Full Text] [Related]
9. Androst-5-ene-7,17-dione: a novel class of suicide substrate of aromatase.
Numazawa M; Mutsumi A; Hoshi K; Tanaka Y
Biochem Biophys Res Commun; 1992 Jul; 186(1):32-9. PubMed ID: 1632774
[TBL] [Abstract][Full Text] [Related]
10. 14 alpha-hydroxyandrost-4-ene-3,6,17-trione as a mechanical-based irreversible inhibitor of estrogen biosynthesis.
Yoshihama M; Tamura K; Nakakoshi M; Nakamura J; Fujise N; Kawanishi G
Chem Pharm Bull (Tokyo); 1990 Oct; 38(10):2834-7. PubMed ID: 2076569
[TBL] [Abstract][Full Text] [Related]
11. Mechanism for aromatase inactivation by a suicide substrate, androst-4-ene-3,6,17-trione. The 4 beta, 5 beta-epoxy-19-oxo derivative as a reactive electrophile irreversibly binding to the active site.
Numazawa M; Mutsumi A; Tachibana M
Biochem Pharmacol; 1996 Oct; 52(8):1253-9. PubMed ID: 8937433
[TBL] [Abstract][Full Text] [Related]
12. Time-dependent aromatase inactivation by 4 beta,5 beta-epoxides of the natural substrate androstenedione and its 19-oxygenated analogs.
Numazawa M; Yoshimura A; Tachibana M; Shelangouski M; Ishikawa M
Steroids; 2002 Mar; 67(3-4):185-93. PubMed ID: 11856542
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of a new series of mechanism-based aromatase inhibitors.
Lesuisse D; Gourvest JF; Hartmann C; Tric B; Benslimane O; Philibert D; Vevert JP
J Med Chem; 1992 May; 35(9):1588-97. PubMed ID: 1578485
[TBL] [Abstract][Full Text] [Related]
14. Inhibition and inactivation of estrogen synthetase (aromatase) by fluorinated substrate analogues.
Marcotte PA; Robinson CH
Biochemistry; 1982 May; 21(11):2773-8. PubMed ID: 7093221
[TBL] [Abstract][Full Text] [Related]
15. Time-dependent inactivation of human placental aromatase by bromoacetoxy 4-androsten-3-ones in the presence of reduced nicotinamide adenine dinucleotide phosphate (NADPH).
Numazawa M; Tsuji M; Mutsumi A; Nagaoka M
Chem Pharm Bull (Tokyo); 1989 Mar; 37(3):735-7. PubMed ID: 2752485
[TBL] [Abstract][Full Text] [Related]
16. Biochemical studies of estr-4-ene-3,6,17-trione and 5 alpha-androstan-17-ones with or without a carbonyl function at C-3 and/or C-6 as aromatase inhibitors.
Numazawa M; Mutsumi A; Tachibana M; Nagaoka M
Biol Pharm Bull; 1995 Apr; 18(4):555-8. PubMed ID: 7655426
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of 6,7-aziridinyl steroids and related compounds as inhibitors of aromatase (P-450arom).
Njar VC; Grün G; Hartmann RW
J Enzyme Inhib; 1995; 9(3):195-202. PubMed ID: 8847599
[TBL] [Abstract][Full Text] [Related]
18. Aromatase inhibitors. Synthesis and biological activity of androstenedione derivatives.
Marsh DA; Brodie HJ; Garrett W; Tsai-Morris CH; Brodie AM
J Med Chem; 1985 Jun; 28(6):788-95. PubMed ID: 4009601
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of human placental aromatase in a perfusion model. Comparison with kinetic, cell-free experiments.
Klein H; Bartsch W; Niemand A; Stürenburg HJ; Voigt KD
J Steroid Biochem; 1988 Feb; 29(2):161-9. PubMed ID: 3347056
[TBL] [Abstract][Full Text] [Related]
20. Inhibition study of human placental aromatase with 3-deoxy- and 6-oxo-steroids using [1 beta-3H]16 alpha-hydroxyandrostenedione as a substrate: a comparison to that using [1 beta-3H]androstenedione.
Numazawa M; Mutsumi A
J Steroid Biochem Mol Biol; 1993 Feb; 44(2):199-201. PubMed ID: 8439524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
